Equity  ||| S:0 E:7 ||| NN
in  ||| S:7 E:10 ||| IN
access  ||| S:10 E:17 ||| NN
to  ||| S:17 E:20 ||| TO
treatment  ||| S:20 E:30 ||| NN
for  ||| S:30 E:34 ||| IN
breast  ||| S:34 E:41 ||| JJ
cancer  ||| S:41 E:48 ||| NN
in  ||| S:48 E:51 ||| IN
Colombia  ||| S:51 E:60 ||| NNP
To  ||| S:60 E:63 ||| TO
evaluate  ||| S:63 E:72 ||| VB
equity  ||| S:72 E:79 ||| NN
in  ||| S:79 E:82 ||| IN
access  ||| S:82 E:89 ||| NN
by  ||| S:89 E:92 ||| IN
comparing  ||| S:92 E:102 ||| VBG
geographic ||| S:102 E:112 ||| JJ
,  ||| S:112 E:114 ||| ,
economic ||| S:114 E:122 ||| JJ
,  ||| S:122 E:124 ||| ,
and  ||| S:124 E:128 ||| CC
organizational  ||| S:128 E:143 ||| JJ
barriers  ||| S:143 E:152 ||| NNS
as  ||| S:152 E:155 ||| IN
well  ||| S:155 E:160 ||| RB
as  ||| S:160 E:163 ||| IN
authorization  ||| S:163 E:177 ||| NN
obstacles  ||| S:177 E:187 ||| NNS
that  ||| S:187 E:192 ||| IN
women  ||| S:192 E:198 ||| NNS
encounter  ||| S:198 E:208 ||| VBP
depending  ||| S:208 E:218 ||| VBG
on  ||| S:218 E:221 ||| IN
their  ||| S:221 E:227 ||| PRP$
affiliation  ||| S:227 E:239 ||| NN
with  ||| S:239 E:244 ||| IN
the  ||| S:244 E:248 ||| DT
social  ||| S:248 E:255 ||| JJ
security  ||| S:255 E:264 ||| NN
health  ||| S:264 E:271 ||| NN
system ||| S:271 E:277 ||| NN
.  ||| S:277 E:279 ||| .
A  ||| S:279 E:281 ||| DT
retrospective  ||| S:281 E:295 ||| JJ
survey  ||| S:295 E:302 ||| NN
was  ||| S:302 E:306 ||| VBD
conducted  ||| S:306 E:316 ||| VBN
among  ||| S:316 E:322 ||| IN
women  ||| S:322 E:328 ||| NNS
undergoing  ||| S:328 E:339 ||| VBG
breast  ||| S:339 E:346 ||| NN
cancer  ||| S:346 E:353 ||| NN
treatment  ||| S:353 E:363 ||| NN
to  ||| S:363 E:366 ||| TO
determine  ||| S:366 E:376 ||| VB
differences  ||| S:376 E:388 ||| NNS
and  ||| S:388 E:392 ||| CC
the  ||| S:392 E:396 ||| DT
degree  ||| S:396 E:403 ||| NN
of  ||| S:403 E:406 ||| IN
fairness  ||| S:406 E:415 ||| NN
in  ||| S:415 E:418 ||| IN
access  ||| S:418 E:425 ||| NN
to  ||| S:425 E:428 ||| TO
care  ||| S:428 E:433 ||| VB
according  ||| S:433 E:443 ||| VBG
to  ||| S:443 E:446 ||| TO
their  ||| S:446 E:452 ||| PRP$
affiliation  ||| S:452 E:464 ||| NN
with  ||| S:464 E:469 ||| IN
the  ||| S:469 E:473 ||| DT
social  ||| S:473 E:480 ||| JJ
security  ||| S:480 E:489 ||| NN
health  ||| S:489 E:496 ||| NN
system ||| S:496 E:502 ||| NN
.  ||| S:502 E:504 ||| .
Women  ||| S:504 E:510 ||| NNS
affiliated  ||| S:510 E:521 ||| VBN
with  ||| S:521 E:526 ||| IN
the  ||| S:526 E:530 ||| DT
subsidized  ||| S:530 E:541 ||| JJ
social  ||| S:541 E:548 ||| JJ
security  ||| S:548 E:557 ||| NN
health  ||| S:557 E:564 ||| NN
system  ||| S:564 E:571 ||| NN
as  ||| S:571 E:574 ||| IN
well  ||| S:574 E:579 ||| RB
as  ||| S:579 E:582 ||| IN
women  ||| S:582 E:588 ||| NNS
living  ||| S:588 E:595 ||| VBG
in  ||| S:595 E:598 ||| IN
rural  ||| S:598 E:604 ||| JJ
areas  ||| S:604 E:610 ||| NNS
have  ||| S:610 E:615 ||| VBP
a  ||| S:615 E:617 ||| DT
greater  ||| S:617 E:625 ||| JJR
probability  ||| S:625 E:637 ||| NN
to  ||| S:637 E:640 ||| TO
travel  ||| S:640 E:647 ||| VB
to  ||| S:647 E:650 ||| TO
another  ||| S:650 E:658 ||| DT
city  ||| S:658 E:663 ||| NN
( ||| S:663 E:664 ||| -LRB-
OR  ||| S:664 E:667 ||| NNP
2.40  ||| S:667 E:672 ||| CD
IC95 ||| S:672 E:676 ||| CD
% ||| S:676 E:677 ||| NN
; ||| S:677 E:678 ||| :
1.64-3.43  ||| S:678 E:688 ||| CD
and  ||| S:688 E:692 ||| CC
OR  ||| S:692 E:695 ||| NNP
1.80  ||| S:695 E:700 ||| CD
IC95 ||| S:700 E:704 ||| CD
% ||| S:704 E:705 ||| NN
; ||| S:705 E:706 ||| :
1.04-3.06 ||| S:706 E:715 ||| CD
,  ||| S:715 E:717 ||| ,
respectively ||| S:717 E:729 ||| RB
) ||| S:729 E:730 ||| -RRB-
.  ||| S:730 E:732 ||| .
Poor  ||| S:732 E:737 ||| JJ
women  ||| S:737 E:743 ||| NNS
without  ||| S:743 E:751 ||| IN
insurance  ||| S:751 E:761 ||| NN
have  ||| S:761 E:766 ||| VBP
greater  ||| S:766 E:774 ||| JJR
probability  ||| S:774 E:786 ||| NN
of  ||| S:786 E:789 ||| IN
having  ||| S:789 E:796 ||| VBG
to  ||| S:796 E:799 ||| TO
pay  ||| S:799 E:803 ||| VB
for  ||| S:803 E:807 ||| IN
medications  ||| S:807 E:819 ||| NNS
( ||| S:819 E:820 ||| -LRB-
OR  ||| S:820 E:823 ||| NNP
3.7  ||| S:823 E:827 ||| CD
IC95 ||| S:827 E:831 ||| CD
% ||| S:831 E:832 ||| NN
; ||| S:832 E:833 ||| :
2.15-6.44 ||| S:833 E:842 ||| CD
) ||| S:842 E:843 ||| -RRB-
.  ||| S:843 E:845 ||| .
Access  ||| S:845 E:852 ||| NN
to  ||| S:852 E:855 ||| TO
breast  ||| S:855 E:862 ||| VB
cancer  ||| S:862 E:869 ||| NN
treatment  ||| S:869 E:879 ||| NN
is  ||| S:879 E:882 ||| VBZ
inequitable  ||| S:882 E:894 ||| JJ
and  ||| S:894 E:898 ||| CC
particularly  ||| S:898 E:911 ||| RB
detrimental  ||| S:911 E:923 ||| VBN
to  ||| S:923 E:926 ||| TO
vulnerable  ||| S:926 E:937 ||| JJ
populations ||| S:937 E:948 ||| NNS
.  ||| S:948 E:950 ||| .
